Product image of Molnex (Morphine Hydrochloride Trihydrate) supplied by GNH India

Molnex

Active Ingredient:
Morphine Hydrochloride Trihydrate
Origin:
EU

Molnex (Morphine Hydrochloride Trihydrate)

Morphine Hydrochloride Trihydrate, the active ingredient in Molnex, is an opioid analgesic presented as a sterile solution for epidural, intramuscular and intravenous use. It is employed to manage moderate to severe pain in adult patients when other analgesics are insufficient.

GNH India supplies Molnex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Molnex, an opioid analgesic, is used in clinical situations that require strong pain relief.

  • Moderate to severe acute pain: provides rapid analgesia for trauma or surgical pain.
  • Post‑operative pain: controls pain after major surgery to facilitate recovery.
  • Cancer‑related pain: alleviates persistent severe pain associated with malignant disease.
  • Labor pain: offers effective analgesia during childbirth when epidural administration is indicated.

How It Works

  • Morphine Hydrochloride Trihydrate acts as a full agonist at central mu‑opioid receptors. Binding to these receptors inhibits the release of neurotransmitters involved in nociceptive transmission, reduces neuronal excitability, and diminishes the perception of pain. The resulting effect is a dose‑dependent analgesic response across spinal and supraspinal pathways.

Side Effects

Morphine Hydrochloride Trihydrate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea and vomiting
  • Constipation
  • Drowsiness or sedation
  • Dizziness or light‑headedness
  • Sweating
  • Itching or pruritus

Serious or Rare Side Effects

  • Respiratory depression
  • Severe hypotension
  • Anaphylactic or severe allergic reaction
  • Adrenal insufficiency
  • Seizures
  • Dependence, tolerance or addiction

Precautions & Warnings

When using Molnex, clinicians should observe several safety measures.

  • Pain assessment: verify the severity and type of pain before initiating therapy.
  • Respiratory monitoring: observe breathing rate and depth, especially after dose adjustments.
  • Organ function: adjust dosing in patients with hepatic or renal impairment.
  • Concomitant CNS depressants: avoid or use with caution when combined with benzodiazepines or barbiturates.
  • Elderly patients: start with the lowest effective dose and monitor closely for adverse effects.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Morphine Hydrochloride Trihydrate interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • Other opioids: additive respiratory depression and sedation.
  • Central nervous system depressants (e.g., benzodiazepines, alcohol): heightened risk of profound sedation.
  • Monoamine oxidase inhibitors (MAOIs): may precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can increase morphine plasma concentrations.
  • CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may alter metabolism and effect.
  • Antihistamines and antihypertensives: may enhance sedative or hypotensive effects.

Frequently Asked Questions

Molnex contains morphine hydrochloride and is indicated for the management of moderate to severe pain, including acute postoperative pain, cancer‑related pain, and pain requiring epidural, intramuscular, or intravenous administration in adult patients.

Morphine hydrochloride is a full agonist at mu‑opioid receptors in the central nervous system. By activating these receptors, it inhibits the release of excitatory neurotransmitters, reduces neuronal firing in pain pathways, and alters the perception of pain, producing dose‑dependent analgesia.

The appropriate dose of Molnex is determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, route of administration, and individual health status. Dosage adjustments are made according to clinical response and safety considerations.

Safety of morphine in pregnancy and lactation is not fully established. Use only if the potential benefit justifies the potential risk to the fetus or infant, and under close medical supervision. Breastfeeding mothers should discuss alternatives with their healthcare provider.

To request Molnex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Molnex delivers morphine, a benchmark opioid with well‑characterized efficacy for severe pain. Compared with newer synthetic opioids, morphine has a longer history of use, a predictable pharmacokinetic profile, and is available in multiple parenteral routes, though it may have a higher incidence of certain side effects such as constipation.

Molnex should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability and potency.

Molnex is supplied as a sterile solution for injection and may be administered epidurally, intramuscularly, or intravenously by a qualified healthcare professional. The route and rate of administration are selected based on the clinical situation and patient needs.

The most serious risks include respiratory depression, severe hypotension, anaphylactic reactions, and the potential for dependence, tolerance, or addiction. Prompt monitoring of respiratory function and vigilance for signs of overdose are essential, especially during dose titration or when combined with other depressants.

Molnex is contraindicated in patients with known hypersensitivity to morphine or any component of the formulation, and in individuals with significant respiratory depression, acute or severe asthma, or paralytic ileus. Caution is also advised for patients with uncontrolled head injury or increased intracranial pressure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Morphine Hydrochloride Trihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT